<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38801978</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence of neutralizing antibodies against HFMD associated enteroviruses among healthy individuals in Shanghai, China, 2022.</ArticleTitle><Pagination><StartPage>694</StartPage><EndPage>698</EndPage><MedlinePgn>694-698</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2024.05.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(24)00077-4</ELocationID><Abstract><AbstractText>• The first report of serological characteristics of HFMD associated enteroviruses in Shanghai after the COVID-19 epidemic. • The seroprevalence of protective NtAbs against Coxsackieviruses was low within the susceptible population of HFMD. • The presence of a silent outbreak and circulation of CVA4 was confirmed among elderly individuals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiayu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wencheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Microbiology Department, Yangpu Municipal Center for Disease Control and Prevention, Shanghai, 200090, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Mingyi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Microbiology Department, Jing'an Municipal Center for Disease Control and Prevention, Shanghai, 200070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jiaying</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Microbiology Department, Changning Municipal Center for Disease Control and Prevention, Shanghai, 200050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Run</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shuangli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>WHO WPRO Regional Polio Reference Laboratory, NHC Key Laboratory for Biosafety, NHC Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wanju</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teng</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Microbiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China. Electronic address: tengzheng@scdc.sh.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="Y">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>28</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38801978</ArticleId><ArticleId IdType="pmc">PMC11401468</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2024.05.008</ArticleId><ArticleId IdType="pii">S1995-820X(24)00077-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gao F., Bian L.L., Chen L., Zhou Y.P., Li G.F., Mao Q.Y., He Q., Wu X., Yao S.S., Yang X.M., Liang Z.L. A cross-sectional seroepidemiology study of seven major enteroviruses causing HFMD in Guangdong, China. J. Infect. 2021;83:119–145.</Citation><ArticleIdList><ArticleId IdType="pubmed">33872666</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Y., Zhang L. Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China. J. Infect. 2022;84:e13–e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8694816</ArticleId><ArticleId IdType="pubmed">34953908</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.C., Huang L.M., Kao C.L., Lu C.Y., Shao P.L., Cheng A.L., Fan T.Y., Chi H., Chang L.Y. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J. Microbiol. Immunol. Infect. 2012;45:96–101.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154997</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Chen Y., Tang A., Gao F., Yan J.B. Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis. Arch. Publ. Health. 2021;79:166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447778</ArticleId><ArticleId IdType="pubmed">34535186</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L., Sun M., Song S., Hu Q., Wang N., Ou G., Guo Z., Du J., Shao Z., Bai Y., Liu K. The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China. J. Med. Virol. 2022;94:3121–3132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088661</ArticleId><ArticleId IdType="pubmed">35277880</ArticleId></ArticleIdList></Reference><Reference><Citation>Song D. Serological survey of hand, foot and mouth disease among healthy people in Hebei district, tianjin city, 2016-2019 year. Medical Information. 2020;33:147–149. (In Chinese)</Citation></Reference><Reference><Citation>Wang J., Liu J., Fang F., Wu J., Ji T., Yang Y., Liu L., Li C., Zhang W., Zhang X., Teng Z. Genomic surveillance of coxsackievirus A10 reveals genetic features and recent appearance of genogroup D in Shanghai, China, 2016-2020. Virol. Sin. 2022;37:177–186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170976</ArticleId><ArticleId IdType="pubmed">35234621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Teng Z., Cui X., Li C., Pan H., Zheng Y., Mao S., Yang Y., Wu L., Guo X., Zhang X., Zhu Y. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016. Emerg. Microb. Infect. 2018;7:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837173</ArticleId><ArticleId IdType="pubmed">29362406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.X., Zhu S.L., Wang J., Lin Y., Pei Y.W., Sun D.P., Zhang Y., Wang X.J., Xu W.B., Ding S.J. Seroprevalence of enterovirus A71 and coxsackievirus A16 in healthy people in shandong province, China. PLoS One. 2016;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5017641</ArticleId><ArticleId IdType="pubmed">27611441</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Liu F., Liao Q., Wu P., Chang Z., Huang J., Long L., Luo L., Li Y., Leung G.M., Cowling B.J., Yu H. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5743100</ArticleId><ArticleId IdType="pubmed">29258646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Van Tan L., Luo K., Liao Q., Wang L., Qiu Q., Zou G., Liu P., Anh N.T., Hong N.T.T., He M., Wei X., Yu S., Lam T.T., Cui J., Van Doorn H.R., Yu H. Genetic variation of multiple serotypes of enteroviruses associated with hand, foot and mouth disease in southern China. Virol. Sin. 2021;36:61–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385209</ArticleId><ArticleId IdType="pubmed">32725479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou J., Yang J., Qiu Q., Wang L., Yang J., Li Y., Liang L., Cui P., Cheng Y., Zheng W., Shi H., Gong H., Wang K., Zhou C., Chu J.J.H., Yu H. Comparison of neutralizing antibody response kinetics in patients with hand, foot, and mouth disease caused by coxsackievirus A16 or enterovirus A71: a longitudinal cohort study of Chinese children, 2017-2019. J. Immunol. 2022;209:280–287.</Citation><ArticleIdList><ArticleId IdType="pubmed">35777850</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.C., Meng F.Y., Li J.X., Li X.L., Mao Q.Y., Tao H., Zhang Y.T., Yao X., Chu K., Chen Q.H., Hu Y.M., Wu X., Liu P., Zhu L.Y., Gao F., Jin H., Chen Y.J., Dong Y.Y., Liang Y.C., Shi N.M., Ge H.M., Liu L., Chen S.G., Ai X., Zhang Z.Y., Ji Y.G., Luo F.J., Chen X.Q., Zhang Y., Zhu L.W., Liang Z.L., Shen X.L. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024–2032.</Citation><ArticleIdList><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Cheng T., Yin Z., Liu D., Xu L., Li Y., Wang W., Liu J., Que Y., Ye X., Tang Q., Zhao Q., Ge S., He S., Xia N. Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population. Emerg. Microb. Infect. 2018;7:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837151</ArticleId><ArticleId IdType="pubmed">29323107</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>